Source: The Economic Times

Followers on Owler

1,450

Est. Annual Revenue

$1.0-5.0B

Est. Employees

5.0-10K

Managing Director

Binish Chudgar

CEO Approval Rating

64/100

Intas is a pharmaceutical company that researches and commercializes tablets, injectables and capsules for cancer and cardiovascular disorders.

Intas acquired UDENYCA for $558.4M